Oxytocin 200 IU ODT

Oxytocin 200 IU ODT (Orally Disintegrating Tablet) is a formulation of the peptide hormone oxytocin designed for sublingual or buccal administration, allowing the tablet to dissolve rapidly in the mouth. Oxytocin is naturally produced in the hypothalamus and released by the posterior pituitary gland, playing a critical role in social bonding, maternal behaviors, uterine contraction, and lactation. Exogenous oxytocin is most commonly administered via injection for obstetric indications, such as labor induction or postpartum hemorrhage. Orally disintegrating tablet (ODT) formulations are primarily used in research or investigational settings to explore oxytocin’s central effects on social cognition, anxiety, and behavior, as peptides delivered orally generally have limited systemic bioavailability due to degradation in the gastrointestinal tract. Sublingual absorption aims to bypass some digestive degradation and allow partial systemic and central nervous system activity. A 200 IU ODT represents a high-dose investigational or research-level concentration. Research studies have explored intranasal or sublingual oxytocin for potential effects on social cognition, stress, and psychiatric disorders: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5839606/ Additional research highlights oxytocin’s roles in bonding, stress modulation, and behavioral effects: https://pubmed.ncbi.nlm.nih.gov/28064682/